Opus Genetics (IRD) Other Operating Expenses (2010 - 2024)
Opus Genetics (IRD) posted quarterly Other Operating Expenses of $28.0 million for Q4 2024, up 234.29% quarter-over-quarter from $8.4 million in Q4 2020.
Opus Genetics (IRD) Other Operating Expenses (2010 - 2024) Analysis & Trends
Opus Genetics (IRD) has reported Other Operating Expenses for 6 consecutive years, with $28.0 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Other Operating Expenses changed N/A year-over-year to $28.0 million; the TTM figure through Sep 2025 stood at $28.0 million (changed N/A YoY), while the FY2024 annual figure was $28.0 million, changed N/A from the prior year.
- Other Operating Expenses climbed to $28.0 million in Q4 2024 per IRD's latest filing, from $8.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $28.0 million in Q4 2024 and bottomed at $2.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 28.00 Mn |
| Dec 31, 2020 | 8.38 Mn |
| Mar 31, 2020 | 2.13 Mn |
| Dec 31, 2013 | -386,102.00 |
| Sep 30, 2013 | 109,844.00 |
| Jun 30, 2013 | 130,451.00 |
| Mar 31, 2013 | 145,807.00 |
| Dec 31, 2012 | 138,789.00 |
| Sep 30, 2012 | 133,292.00 |
| Jun 30, 2012 | 88,094.00 |
| Mar 31, 2012 | 113,310.00 |
| Dec 31, 2011 | 182,030.00 |
| Sep 30, 2011 | 208,551.00 |
| Jun 30, 2011 | 113,875.00 |
| Mar 31, 2011 | 86,641.00 |
| Dec 31, 2010 | 107,652.00 |
| Sep 30, 2010 | 134,810.00 |
| Jun 30, 2010 | 73,841.00 |